Multiple Sclerosis Clinical Trials in Houston

Showing 501-520 of 606 trials

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

NCT00042328

The purpose of this research is to study the pharmacology (how the body handles this drug) of valacyclovir in children receiving treatment for cancer. This study will last approximately 7 days.

Neoplasms

Baylor College of Medicine30 participantsStarted Aug 2001

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

NCT00044291

The purpose of this study is to determine whether the first line combination hormonal therapy of an experimental drug, atamestane, plus an FDA-approved drug, toremifene (Fareston®), is more effective than another approved drug, letrozole (Femara®), in delaying the growth of breast cancer in postmenopausal patients with locally advanced or metastatic breast cancer, and whether the side effects of the combination are different from the side effects of letrozole.

Breast NeoplasmsNeoplasms, Hormone-dependent

Intarcia Therapeutics865 participantsStarted Jun 2002

Lake Havasu City, Arizona, United States • Tucson, Arizona, United States • Greenbrae, California, United States +60 more locations

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Multiple Sclerosis Trials in Other Cities

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Natalizumab High Titer Immunogenicity and Safety

Safety Study for the Treatment of Abdominal Aortic Aneurysms

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Other Conditions in Houston